Truvestments Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Truvestments Capital's AMGN Position: Q2 2026 in Review
Truvestments Capital reduced its Amgen (AMGN) stake by 2.3% in Q2 2026, selling an estimated $20.2K and leaving 2,481 shares worth $899K. The position accounts for 0.13% of the portfolio, ranked #155.
Truvestments Capital first reported a position in AMGN in Q3 2018 and has held it in 21 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Truvestments Capital held 2,481 shares of Amgen worth $899K as of Q2 2026.
- Truvestments Capital sold 59 Amgen shares in Q2 2026, an estimated $20.2K.
- Amgen made up 0.13% of Truvestments Capital's portfolio in Q2 2026, its #155 holding.
- Truvestments Capital first reported a position in Amgen in Q3 2018 and has held it in 21 quarters since.
- 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.